Home
Conditions
Non-small Cell Lung Cancer

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 329 recruiting studies

Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Recruiting

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

NCT06041776

Conditions: Adjuvant Therapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Peking University International Hospital Beijing, China

Jiangsu Cancer Hospital Nanjing, China

Shanghai chest hospital Shanghai, China

View Trial Details

Recruiting

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

NCT06043466

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +40 more
Locations: The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

NCT05800340

Conditions: BRAF V600 Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guanzhou, Guangdong, China

View Trial Details

Recruiting

Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA

NCT05334277

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The First Hospital of Jilin University Changchun, China

Sichuan Provincial People's Hospital Chengdu, China

Dongguan People's Hospital Dongguan, China

Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang People's hospital Dongyang, China

View all 26 locations

View Trial Details

Recruiting

A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer

NCT04951635

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shandong Cancer Hospital Ji'nan, Shandong, China

View Trial Details

Recruiting

Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC

NCT05172739

Conditions: Anesthesia, Bronchial Neoplasms, Carcinoma, Bronchogenic, +23 more
Locations: University of Crete Heraklion, Crete, Greece

View Trial Details

Recruiting

A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer

NCT05104788

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: BeijingCancerH Beijing, China

View Trial Details

Recruiting

A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases

NCT05033691

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +18 more
Locations: Hadassah Ein Kerem Medical Center Jerusalem, Israel

View Trial Details

Recruiting

Cell Free DNA for the Diagnosis and Treatment in Early NSCLC

NCT03791034

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Enrolling by Invitation

Harvesting Cells for Experimental Cancer Treatments

NCT00068003

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +31 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Non-small Cell Lung Cancer

Non-small Cell Lung Cancer trial results

Related conditions